AzTrials
AzTrials

SurgeryMEPONCT06480370

Optimization of Transcranial Motor Evoked Potentials in Supratentorial Surgeries

A study testing ISIS IOM System in people with Surgery, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This project aims to optimize the methodology to elicite transcranial motor evoked potentials in intraoperative neurophysiological monitoring of brain surgery. It includes accelerometer measurements and microscope video image to determine movement of the surgical field, making possible minimization of movement during… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Surgery
What is being tested?
ISIS IOM System
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
203 participants
Where
1 siteSwitzerland
Study dates
20 Feb 2025to Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Informed consent signed by the subject
  • The patient has a supra-tentorial lesion requiring surgery
  • The patient is undergoing neurosurgery with the use of MEP monitoring during surgery to protect functional tissue* (During routine preparation for the surgery, patients are checked for any relative contraindications as listed in the user manual of the ISIS IOM System (see p. 11, chapter 2.2.4 of the user manual). Every relative contraindication must be weighed against the risk and benefits of the measurement signals which are routinely needed for the surgical intervention. There are no absolute contraindications for the ISIS IOM System.)
  • The patient is older than 18 years

Who cannot join

  • No need for MEP monitoring
  • Vulnerable subjects (pregnant, impaired consciousness)
  • People who do not want to participate in the study
  • Emergency procedures in which no consent was obtained before the operation
  • Multiple surgeries on the same patient
  • Preoperative non-affected arm or leg motor deficit (MRC <5), that is to say, no motor deficit of the arm or leg ipsilateral to the surgery
Show all 9Show fewer
  • Inhalational anesthesia
  • Persisting neuromuscular blockade
  • Impossibility to place the stimulating or recording electrodes in the appropriate site

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Seidel Kathleen, MD contact

+41 31 632 57 88

kathleen.seidel@insel.ch

Pablo Abel Alvarez Abut, MD contact

pabloabel.alvarezabut@insel.ch

Switzerland1 site, 1 recruiting
  • Dep. of Neurosurgery, Bern University Hospital

    Bern, 3010

    Kathleen Seidel, MD, +41316322409, kathleen.seidel@insel.ch

    Pablo Abel Alvarez Abut, MD, pabloabel.alvarezabut@insel.ch

    Recruiting

Other trials in Switzerland

About this study

This project aims to optimize the methodology to elicite transcranial motor evoked potentials in intraoperative neurophysiological monitoring of brain surgery. It includes accelerometer measurements and microscope video image to determine movement of the surgical field, making possible minimization of movement during brain stimulation.

Read the detailed description

Background: During supratentorial brain surgery there is a risk of iatrogenic injury resulting in post-operative motor deficits. Intraoperative neurophysiological monitoring (IONM) can help surgeons avoid this outcome, while also expanding evidence of its prognostic and preventive benefit (1, 2). However, there are still pending issues, such as standardization of optimal methodologies for data acquisition and interpretation as well as technical improvement.

There are two main IONM strategies: mapping to localize nervous structures, and monitoring to provide real-time assessment of functional integrity (3). With respect to monitoring, muscle motor evoked potentials (MEPs) enable motor system assessment. They can be elicited by pulse train transcranial electric stimulation (TES) through scalp electrodes placed at standard 10-20 system sites (C1, C2, C3, C4, Cz-1cm, Cz+6cm), or at neuronavigation-guided scalp sites. The stimulation circuit consists of the user-selected anode and cathode sites chosen from the scalp electrodes (4). The stimulation parameters are user-selected pulse duration, interstimulus interval (ISI), number of pulses, and single train stimulation vs. double-train or multi-train facilitation. MEP threshold is the stimulation intensity required to elicit a certain number of MEPs with a predefined amplitude. The recording montage consists of user-selected recording electrode orientation and target muscles. Practitioner preferences for these technical aspects vary widely (5), and can influence monitoring efficacy.

During surgery, significant MEP deterioration from an earlier baseline indicates a warning based on various criteria such as amplitude reduction or threshold elevation (2). Warnings trigger rescue manoeuvres to recover MEPs. With reversible MEP deterioration (recovery to values above the warning level), a post-operative motor deficit might be prevented. Continuous real-time monitoring facilitates this favourable result by providing early warnings, and is therefore important. With irreversible MEP deterioration there is an increased risk of a motor deficit (1), and discontinuous intermittent monitoring may fail to help prevent this adverse outcome.

A major concern regarding TES MEPs is that the stimuli often produce movement of the surgical field, which entails the risk of the patient being harmed by surgical manoeuvres if they are not paused during the measurements (4). This can delay the surgical procedure and/or preclude real-time monitoring. Thus, there is a need to establish optimal TES MEP methodology that minimizes objectively assessed movement.

Objective: The hypothesis of this project is that MEP stimulation and recording paradigms can be optimized to minimize movement of the surgical field during supratentorial brain surgery. Consequently, the overall aim is to identify the most effective stimulation and recording techniques to maximize TES MEP performance by minimizing movement. The specific objectives are to determine:

  1. The best stimulation circuit to elicit MEPs with the lowest possible movement;
  2. The best stimulation parameters to elicit MEPs with the lowest possible movement;
  3. The best recording montages to obtain MEPs with the lowest possible stimulation threshold.

Methods: General methods: Adult patients undergoing routine brain surgery with IONM and giving informed consent will be eligible. Muscle MEP recordings will be performed from limbs ipsilateral to the operation side. Patients with preoperative ipsilateral motor impairment will be excluded. Movement and MEP threshold will be the primary endpoints. Movement will be assessed through one accelerometer on the forehead (with quantification through kinetic energy). For comparison (secondary endpoint), another accelerometer on the ipsilateral shoulder to the recording site will be used, as well as the subjective evaluation by the surgeon on an ordinal scale, through visualization of the surgical field. Additionally, we propose to quantify the magnitude of motion using post-processing of digital images from the surgical microscope.

Comparative analyses of movement and MEP thresholds will be performed by successively varying one of the variables and keeping the others at Inselspital standard. Videos of the surgical field will be recorded with the microscope for all the proposed experimental setups, to recover the images for the quantification of the movement.

The study will be divided into four different parts, each of them with different steps (outlined below). Consequently, each patient participates in a specific part and stepThis subdivision is necessary due to time constraints in the operating room, as it would not be feasible to perform all the different combinations on every patient.

Patients who have already been included in the study and require a redo surgery will also be eligible for inclusion in a different part or step of the study.

Threshold current will be defined as the minimum current to elicit MEP responses with an amplitude higher than 20 µV in at least 5 consecutive trials. The procedure will be to increase current until MEPs appear, then reduce current until they disappear, and then finely adjust current to the minimum for a consistent response.

Part 1: determination of the best stimulation circuit. Step 1 - comparison of 10-20 system stimulation circuits: Evaluation of 12 patients. Circuits of C1/C2, C3/C4, and C3 or C4/Cz-1cm for upper limb MEPs, and C1/C2, C3/C4, and Cz-1cm/Cz+6cm for lower limb MEPs. Acquisition of 12 MEPs per limb with each circuit.

Step 2 - comparison of the best Step 1 circuit to the neuronavigation-guided stimulation circuit: Evaluation of 16 patients. Acquisition of 22 upper limb MEPs with each circuit.

Part 2: determination of the best stimulation parameters. Step 1 - comparison of different pulse durations: Evaluation of 21 patients. Pulse duration of 100, 200, 350, 500, 650, 800, and 1000 µs. Acquisition of 21 upper limb MEPs with each pulse duration.

Step 2 - comparison of different ISIs: Evaluation of 30 patients (15 per limb). ISI of 1, 2, 3, 4, and 5 ms. Acquisition of 20 upper and lower limb MEPs with each ISI.

Step 3 - comparison of different numbers of pulses: Evaluation of 15 patients. Number of pulses of 3, 4, 5, 7, and 9. Acquisition of 20 upper limb MEPs with each number of pulses.

Step 4 - comparison of single train to double-train facilitation at different inter train intervals (ITIs): Evaluation of 21 patients. Single train, double train (2/7 and 4/4 pulses). ITI of 20, 85, and 150 ms. Acquisition of 21 upper limb MEPs with each paradigm.

Step 5 - comparison of single train to multi-train facilitation at different rates: Evaluation of 21 patients. Single train at rate of 0.5 Hz. Multi-train facilitation at rates of 1, 2, 3, 4, 5, and 6 Hz. Acquisition of 21 upper limb MEPs with each paradigm.

Part 3: determination of the best recording montages. Step 1 - comparison of recording electrode orientations: Evaluation of 12 patients. Recordings from extensor digitorum communis (EDC) and tibialis anterior (TA). Three recording orientations: 1) bipolar perpendicular to muscle fibres, 2) bipolar parallel to muscle fibres, and 3) referential to the distal muscle tendon. Determination of threshold* per orientation within each muscle.

Step 2 - determination of muscles of choice in distal upper limbs: Evaluation of 21 patients. Recordings from abductor pollicis brevis (APB), abductor digiti minimi (ADM), first dorsal interosseous, EDC, flexor carpi radialis (FCR), APB/ADM, and EDC/FCR. Determination of threshold* for all muscles.

Step 3 - determination of muscles of choice in distal lower limbs: Evaluation of 18 patients. Recordings from abductor hallucis (AH), extensor digitorum brevis (EDB), TA, soleus, AH/EDB, and TA/soleus. Determination of threshold* for all muscles.

Part 4: Evaluation of 16 patients. Comparison of best stimulation and recording methodology from the results of Parts 1 to 3 with the current standard in our department. Acquisition of 22 MEPs per limb by paradigm.

Conditions
Surgery
Being tested
ISIS IOM System

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ISIS IOM SystemDevice

    Application of TES at different stimulation circuits, with different stimulation parameters and recording montages.

Study groups in NCT06480370
Study groupRoleWhat they receive
Study ArmExperimentalApplication of TES at different stimulation circuits, with different stimulation parameters and recording montages.
Receives: Device: ISIS IOM System

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. threshold of stimulation and patient movement

    threshold of stimulation and patient movement quantified by an accelerometer placed on the forehead of the patient

    Measured: during surgery

Secondary outcomes (3)
  1. patient movement

    patient movement quantified by an accelerometer on the shoulder

    Measured: during surgery

  2. subjective evaluation of magnitude of motion

    subjective evaluation by the surgeon of magnitude of motion using post-processing of digital images from the surgical microscope

    Measured: end of surgery

  3. quantification of magnitude

    quantification of magnitude of motion using post-processing of digital images from the surgical microscope

    Measured: end of surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jun 2024
  2. Study start20 Feb 2025
  3. Primary completion30 Jun 2028 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
203 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06480370
Sponsor's protocol ID
2024-D0039
Acronym
MEPO
Status last verified
Apr 2026
First submitted
24 Jun 2024
Last updated
1 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Holdefer RN, Skinner SA. Commentary : The value of intraoperative neurophysiological monitoring: evidence, equipoise and outcomes. J Clin Monit Comput. 2017 Aug;31(4):657-664. doi: 10.1007/s10877-016-9910-0. Epub 2016 Aug 1.

    PubMed 27481235
  • Asimakidou E, Abut PA, Raabe A, Seidel K. Motor Evoked Potential Warning Criteria in Supratentorial Surgery: A Scoping Review. Cancers (Basel). 2021 Jun 4;13(11):2803. doi: 10.3390/cancers13112803.

    PubMed 34199853
  • Seidel K, Beck J, Stieglitz L, Schucht P, Raabe A. The warning-sign hierarchy between quantitative subcortical motor mapping and continuous motor evoked potential monitoring during resection of supratentorial brain tumors. J Neurosurg. 2013 Feb;118(2):287-96. doi: 10.3171/2012.10.JNS12895. Epub 2012 Nov 30.

    PubMed 23198802
  • Macdonald DB, Skinner S, Shils J, Yingling C; American Society of Neurophysiological Monitoring. Intraoperative motor evoked potential monitoring - a position statement by the American Society of Neurophysiological Monitoring. Clin Neurophysiol. 2013 Dec;124(12):2291-316. doi: 10.1016/j.clinph.2013.07.025. Epub 2013 Sep 18.

    PubMed 24055297
  • Dulfer SE, Gadella MC, Sahinovic MM, Lange F, Absalom AR, Groen RJM, Szelenyi A, Drost G. Stimulation parameters for motor evoked potentials during intraoperative spinal cord monitoring. A systematic review. Clin Neurophysiol. 2023 May;149:70-80. doi: 10.1016/j.clinph.2023.02.170. Epub 2023 Mar 4.

    PubMed 36924672
  • Fujii M, Maesawa S, Motomura K, Futamura M, Hayashi Y, Koba I, Wakabayashi T. Intraoperative subcortical mapping of a language-associated deep frontal tract connecting the superior frontal gyrus to Broca's area in the dominant hemisphere of patients with glioma. J Neurosurg. 2015 Jun;122(6):1390-6. doi: 10.3171/2014.10.JNS14945. Epub 2015 Mar 27.

    PubMed 25816090
  • Kapsalakis IZ, Kapsalaki EZ, Gotsis ED, Verganelakis D, Toulas P, Hadjigeorgiou G, Chung I, Fezoulidis I, Papadimitriou A, Robinson JS, Lee GP, Fountas KN. Preoperative evaluation with FMRI of patients with intracranial gliomas. Radiol Res Pract. 2012;2012:727810. doi: 10.1155/2012/727810. Epub 2012 Jul 12.

    PubMed 22848821
  • Moiyadi A, Velayutham P, Shetty P, Seidel K, Janu A, Madhugiri V, Singh VK, Patil A, John R. Combined Motor Evoked Potential Monitoring and Subcortical Dynamic Mapping in Motor Eloquent Tumors Allows Safer and Extended Resections. World Neurosurg. 2018 Dec;120:e259-e268. doi: 10.1016/j.wneu.2018.08.046. Epub 2018 Aug 21.

    PubMed 30138733
  • Raabe A, Beck J, Schucht P, Seidel K. Continuous dynamic mapping of the corticospinal tract during surgery of motor eloquent brain tumors: evaluation of a new method. J Neurosurg. 2014 May;120(5):1015-24. doi: 10.3171/2014.1.JNS13909. Epub 2014 Mar 14.

    PubMed 24628613
  • Schucht P, Seidel K, Beck J, Murek M, Jilch A, Wiest R, Fung C, Raabe A. Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome. Neurosurg Focus. 2014 Dec;37(6):E16. doi: 10.3171/2014.10.FOCUS14524.

    PubMed 25434385

Questions about this trial

What is this clinical trial studying?

A study testing ISIS IOM System in people with Surgery, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Seidel Kathleen, MD (+41 31 632 57 88, kathleen.seidel@insel.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

threshold of stimulation and patient movement (time frame: during surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06480370, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in